Aardvark Therapeutics, Inc. Common Stock
AARD
$3.78-2.07%
Delayed · as of Oct 16, 2026, 2:30 PM ET
Mkt cap
$284.41M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-3.22
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Use this AARD research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AARD income, balance, and cash tables.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company in the Healthcare sector.
Latest cached Aardvark Therapeutics, Inc. Common Stock (AARD) net income for Dec 31, 2025 was -$57.6M. Statements: https://lician.com/financials/aard
Aardvark Therapeutics, Inc. Common Stock (AARD) market capitalization is $284.4M on the latest cached snapshot.
Aardvark Therapeutics, Inc. Common Stock (AARD) cached previous close $3.86; day range $3.78 – $4.19; volume 64,258. Session quote: https://lician.com/quote/aard
Aardvark Therapeutics, Inc. Common Stock (AARD) latest cached earnings event is "AARD earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AARD filing is 8-K · Oct 23, 2026. Filings: https://lician.com/sec/aard